Frontotemporal Dementia Clinical Trials

12 recruiting

Frequently Asked Questions

Common questions about Frontotemporal Dementia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting

Retinal Imaging in Neurodegenerative Disease

Traumatic Brain InjuryHuntington DiseaseNeuro-Degenerative Disease+12 more
Duke University2,000 enrolled1 locationNCT03233646
Recruiting

Comprehensive Assessment of Neurodegeneration and Dementia

DementiaMild Cognitive Impairment (MCI)Subjective Cognitive Impairment+7 more
McGill University1,573 enrolled19 locationsNCT03402919
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

DementiaAlzheimer DiseaseParkinson Disease+7 more
University Health Network, Toronto500 enrolled4 locationsNCT06529744
Recruiting
Not Applicable

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

Alzheimer DiseaseDementia With Lewy BodiesFrontotemporal Dementia
Kuopio University Hospital200 enrolled1 locationNCT05326750
Recruiting
Not Applicable

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

ParagangliomaPheochromocytomaGenetic Predisposition+7 more
University of Pennsylvania1,000 enrolled1 locationNCT06377033
Recruiting
Not Applicable

Neurologic Stem Cell Treatment Study

Cognitive ImpairmentDementiaTraumatic Brain Injury+23 more
MD Stem Cells500 enrolled3 locationsNCT02795052
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

Alzheimer DiseaseFrontotemporal Dementia
University Hospital, Lille102 enrolled1 locationNCT05288842
Recruiting
Phase 1Phase 2

First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia

DementiaAlzheimer DiseaseFrontotemporal Dementia
David Wilson102 enrolled1 locationNCT05374278
Recruiting
Early Phase 1

[18F]ACI-19626 PET in TDP-43 Proteinopathies

Amyotrophic Lateral Sclerosis(ALS)Alzheimer's Disease(AD)Frontotemporal Dementia (FTD)+2 more
AC Immune SA45 enrolled1 locationNCT06891716
Recruiting

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

Parkinson DiseaseAmyotrophic Lateral Sclerosis(ALS)Alzheimer&Amp;#39;s Disease (AD)+1 more
Neuromed IRCCS110 enrolled1 locationNCT06803784
Recruiting

ALS Research Collaborative

Amyotrophic Lateral SclerosisMotor Neuron DiseaseALS (Amyotrophic Lateral Sclerosis)+2 more
ALS Therapy Development Institute2,000 enrolled1 locationNCT06885918
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting

Proteinopathies Expression in Skin of Neurodegenerative Disorders

Amyotrophic Lateral SclerosisAlzheimer DiseaseParkinson Disease+3 more
Universidad Autonoma de San Luis Potosí40 enrolled1 locationNCT06528964
Recruiting

ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions

Alzheimer DiseaseFrontotemporal Dementia, Behavioral Variant
Institut National de la Santé Et de la Recherche Médicale, France120 enrolled1 locationNCT04865172
Recruiting

Autobiographical Specificity

Alzheimer DiseaseFrontotemporal DementiaMemory
Nantes University Hospital62 enrolled1 locationNCT05642351
Recruiting

Longitudinal Cognitive Assessment by BoCA

Multiple SclerosisAlzheimer DiseaseParkinson Disease+4 more
Alzheimer's Light LLC10,000 enrolled1 locationNCT04114994
Recruiting

Cerebro Spinal Fluid Collection (CSF)

Multiple System AtrophyAlzheimer DiseaseDementia With Lewy Bodies+2 more
University Hospital, Strasbourg, France10,000 enrolled1 locationNCT04844060